Description

Plutoheat Pharmaceutical has always been committed to serving human health, providing safe, effective, and high-quality medicines to people around the world. The company has engaged in in-depth international cooperation with many leading pharmaceutical manufacturers in China, which not only have China GMP certification but also many regulatory GMP certifications in various markets, including the United States, EU member states, Japan, Australia, and others. In addition to chemical generic drugs, Plutoheat Pharmaceutical also focuses on products such as monoclonal antibodies.

In addition to high-quality partners and products with market potential, the company also possesses a professional registration team well-versed in the regulatory requirements of numerous international markets. With advanced capabilities in preparing registration documents, the team has completed CTD (Chemistry, Technology, and Data) files for dozens of products, providing robust assurance for the export of our pharmaceutical formulations to the global market.

Through the persistent efforts of the team over the years, we have exported China's medicines to more than 20 countries and regions worldwide.